Abstract
Detailed analysis of hepatitis C virus (HCV) has been hampered by the lack of an appropriate viral culture system and small animal models of infection. My group and others have recently reported the production of infectious virus after full-length HCV RNA transfection into Huh-7 cells. This system depends primarily on isolation of a JFH-1 strain from a patient with fulminant hepatitis. The JFH-1 strain belongs to genotype 2a and has high colony-formation efficiency when tested with a subgenomic replicon system. Here, I describe various protocols for isolation of the JFH-1 strain and construction of the HCV infection system. The HCV infection system contributes to our understanding of HCV virology and may permit development of novel antiviral strategies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bartenschlager, R. and Lohmann, V. (2001) Novel cell culture systems for the hepatitis C virus. Antiviral Res. 52, 1–17.
Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L., and Bartenschlager, R. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110–113.
Blight, K. J., Kolykhalov, A. A., and Rice, C. M. (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972–1974.
Lohmann, V., Korner, F., Dobierzewska, A., and Bartenschlager, R. (2001) Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J. Virol. 75, 1437–1449.
Krieger, N., Lohmann, V., and Bartenschlager, R. (2001) Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol. 75, 4614–4624.
Ikeda, M., Yi, M., Li, K., and Lemon, S. M. (2002) Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J. Virol. 76, 2997–3006.
Pietschmann, T., Lohmann, V., Kaul, A., Krieger, N., Rinck, G., Rutter, G., et al. (2002) Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J. Virol. 76, 4008–4021.
Blight, K. J., McKeating, J. A., Marcotrigiano, J., and Rice, C. M. (2003) Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J. Virol. 77, 3181–3190.
Bukh, J., Pietschmann, T., Lohmann, V., Krieger, N., Faulk, K., Engle, R. E., et al. (2002) Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc. Natl. Acad. Sci. USA 99, 14416–14421.
Kato, T., Furusaka, A., Miyamoto, M., Date, T., Yasui, K., Hiramoto, J., et al. (2001) Analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J. Med. Virol. 64, 334–339.
Kato, T., Date, T., Miyamoto, M., Furusaka, A., Tokushige, K., Mizokami, M., et al. (2003) Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125, 1808–1817.
Uprichard, S. L., Chung, J., Chisari, F. V., and Wakita, T. (2006) Replication of a hepatitis C virus replicon clone in mouse cells. Virol. J. 3, 89.
Date, T., Miyamoto, M., Kato, T., Morikawa, K., Murayama, A., Akazawa, D., et al. (2007) An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain. Hepatol. Res. in press.
Kato, T., Date, T., Miyamoto, M., Sugiyama, M., Tanaka, Y., Orito, E., et al. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. J. Clin. Microbiol. 43, 5679–5684.
Date, T., Kato, T., Miyamoto, M., Zhao, Z., Yasui, K., Mizokami, M., et al. (2004) Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells. J. Biol. Chem. 279, 22371–22376.
Kato, T., Date, T., Miyamoto, M., Zhao, Z., Mizokami, M., and Wakita, T. (2005) Non-hepatic cell lines HeLa and 293 cells support efficient replication of hepatitis C virus genotype 2a subgenomic replicon. J. Virol. 79, 592–596.
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791–796.
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., et al. (2005) Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102, 9294–9299.
Blight, K. J., McKeating, J. A., and Rice, C. M. (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76, 13001–13014.
Sumpter, R., Jr., Loo, Y. M., Foy, E., Li, K., Yoneyama, M., Fujita, T., et al. (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNAreplication through a cellular RNA helicase, RIG-I. J. Virol. 79, 2689–2699.
Lindenbach, B. D., Evans, M. J., Syder, A. J., Wolk, B., Tellinghuisen, T. L., Liu, C. C.,et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309, 623–626.
Koutsoudakis, G., Herrmann, E., Kallis, S., Bartenschlager, R., and Pietschmann, T. (2007) The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J. Virol. 81, 588–598.
Akazawa, D., Date, T., Morikawa, K., Murayama, A., Miyamoto, M., Kaga, M., et al. (2007) CD81 expression is important for heterogeneous HCV permissiveness of Huh7 cell clones. J. Virol. [Epub ahead of print].
Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T., and Sato, J. (1982) Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42, 3858–3863.
Koutsoudakis, G., Kaul, A., Steinmann, E., Kallis, S., Lohmann, V., Pietschmann, T., et al. (2006) Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80, 5308–5320.
Morikawa, K., Zhao, Z., Date, T., Miyamoto, M., Murayama, A., Akazawa, D., et al. (2007) The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles. J. Med. Virol. in press.
Kapadia, S. B., Barth, H., Baumert, T.,McKeating, J. A., and Chisari, F. V. (2007) Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 81, 374–383.
Grove, J., Huby, T., Stamataki, Z., Vanwolleghem, T., Meuleman, P., Farquhar, M., et al. (2007) Scavenger receptor BI and BII expression levels modulate Hepatitis C virus infectivity. J Virol. [Epub ahead of print].
Blanchard, E., Belouzard, S., Goueslain, L., Wakita, T., Dubuisson, J., Wychowski, C.,et al. (2006) Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol. 80, 6964–6972.
Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wolk, B., (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature [Epub ahead of print].
Kanda, T., Basu, A., Steele, R., Wakita, T., Ryerse, JS., Ray, R., et al. (2006) Generation of infectious hepatitis C virus in immortalized human hepatocytes. J. Virol. 80, 4633–4639.
Wagoner, J., Austin, M., Green, J., Imaizumi, T., Casola, A., Brasier, A., et al. Regulation of CXCL-8 (interleukin 8) induction by dsRNA signaling pathways during hepatitis C virus infection. J. Virol. 81, 309–318.
Larrea, E., Riezu-Boj, J. I., Gil-Guerrero, L., Casares, N., Aldabe, R., Sarobe, P., et al. (2007) Upregulation of indoleamine 2,3 dioxygenase in hepatitis C virus infection. J. Virol. [Epub ahead of print].
Francesco, R. D., and Migliaccio, G. (2005) Challenges and successes in developing new therapies for hepatitis C. Nature 436, 953–960.
Cai, Z., Zhang, C., Chang, K-Y., Jiang, J., Ahn, B-C., Wakita, T., et al. (2005) Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J. Virol. 79, 13963–13973.
Kato, T., Matsumura, T., Heller, T., Saito, S., Sapp, R. K., Murthy, K., et al. (2007) Production of infectious hepatitis C virus of various genotypes in cell culture. J. Virol. [Epub ahead of print].
Rouillé, Y., Helle, F., Delgrange, D., Roingeard, P., Voisset, C., Blanchard, E., et al. (2006) Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J. Virol. 80, 2832–2841.
Shirakura, M., Murakami, K., Ichimura, T., Suzuki, R., Shimoji, T., Fukuda, K., et al. (2007) The E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J. Virol. 81, 1174–1185.
Houghton, M. and Abrignani, S. (2005) Prospects for a vaccine against the hepatitis C virus. Nature 436, 961–966.
Meunier, J. C., Engle, R. E., Faulk, K., Zhao, M., Bartosch, B., Alter, H., et al. (2005) Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc. Natl. Acad. Sci. USA 102, 4560–4565.
Yi, M., Villanueva, R. A., Thomas, D. L., Wakita, T., and Lemon, S. M. (2006) Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc. Natl. Acad. Sci. USA 103, 2310–2315.
van den Hoff, M. J., Moorman, A. F., and Lamers, W. H. (1992) Electroporation in “intracellular” buffer increases cell survival. Nucleic Acids Res. 20, 2902.
Kato, T., Date, T., Murayama, A., Morikawa, K., Akazawa, D., and Wakita, T. (2006) Cell culture and infection system for hepatitis C virus. Nature Protocols 1, 2334–2339.
Reed, L. J. and Muench, H. A. (1938) Simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27493–27497.
Acknowledgements
This work was partially supported by a grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science, from the Ministry of Health, Labour and Welfare of Japan, and from the Ministry of Education, Culture, Sports, Science and Technology and by the Research on Health Sciences Focusing on Drug Innovation from the Japan Health Sciences Foundation.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Wakita, T. (2009). Isolation of JFH-1 Strain and Development of an HCV Infection System. In: Tang, H. (eds) Hepatitis C. Methods in Molecular Biology™, vol 510. Humana Press. https://doi.org/10.1007/978-1-59745-394-3_23
Download citation
DOI: https://doi.org/10.1007/978-1-59745-394-3_23
Publisher Name: Humana Press
Print ISBN: 978-1-58829-970-3
Online ISBN: 978-1-59745-394-3
eBook Packages: Springer Protocols